降压药依普利酮医保报销吗
Are antihypertensive drugs reimbursed by medical insurance? At present, eplerenone is not yet on the market in China, and it is not included in the medical insurance catalog. Patients cannot be reimbursed by medical insurance after purchasing the drug.
Eplerenone is used for the treatment of essential hypertension and heart failure after myocardial infarction. Its antagonism to aldosterone is stronger than that of spironolactone, and it has extremely low affinity for androgen and progesterone receptors and has few adverse reactions. It has a positive therapeutic effect in the treatment of hypertension, heart failure and myocardial infarction, and is well tolerated. It is a good alternative to spironolactone.
Without damaging the organs, eplerenone has a protective effect on the liver, heart disease, and kidneys. Not only that, it can also promote urination without losing potassium. Eplerenone also has a good antihypertensive effect on simple systolic hypertension and has a good antihypertensive effect on diet-induced obesity-related hypertension. In addition, eplerenone can significantly reduce the ultrafiltration effect of glomeruli and reduce albuminuria in patients with hypertension. This renal protective effect is more obvious for hypertensive patients with diabetes.
The EPHESUS trial showed that for patients with left ventricular ejection fraction (LVEF) <40% and heart failure within 3 to 14 days after myocardial infarction, adding eplerenone to standard treatment can reduce all-cause death by 15%, primary combined endpoints (cardiovascular death or hospitalization for cardiovascular events) by 17%, and sudden cardiac death by 21%.
According to data from multiple clinical trials, the therapeutic effect of (eplerenone) is significant. The successful development of this drug is good news for many patients. However, patients cannot blindly use this drug for treatment. Before receiving this drug for treatment, patients should go to the hospital for a detailed examination and take the drug according to the doctor's diagnosis and treatment recommendations.
Recommended related hot articles: /newsDetail/79916.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)